| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |